about
The value of body weight measurement to assess dehydration in childrenRisk of bacterial meningitis in young children with a first seizure in the context of fever: a systematic review and meta-analysis.Clinical decision rules for evaluating meningitis in children.Predicting the risk of severe infection in children with chemotherapy-induced febrile neutropenia.Consensus in diagnostic definitions for bone or joint infections in children by a Delphi method with European French-speaking experts.Predicting the risk of severe bacterial infection in children with chemotherapy-induced febrile neutropenia.Increased detection rate of Kawasaki disease using new diagnostic algorithm, including early use of echocardiography.Impressive renal damage after acute pyelonephritis in a child.Imported malaria in children: incidence and risk factors for severity.National survey reported that French paediatric residents had access to simulation-based training but needed moreDistinguishing between bacterial and aseptic meningitis in children: European comparison of two clinical decision rulesSensitivity of the Bacterial Meningitis Score in 889 Children with Bacterial MeningitisProcalcitonin to Reduce the Number of Unnecessary Cystographies in Children with a Urinary Tract Infection: A European Validation StudySerum procalcitonin and other biologic markers to distinguish between bacterial and aseptic meningitisDetection of (1,3)-β-D-glucans in situ in a Candida albicans brain granuloma[Meningococcal purpura fulminans in children][Prophylaxis for contacts of an index case of hepatitis A: immunoglobulins or vaccination?]Can we apply the European surveillance program of nosocomial infections (HELICS) to pediatric intensive care units?Infants refusing to walkInvasive serogroup w meningococcal disease in children: a national survey from 2001 to 2008 in FranceVaccination coverage of children with chronic diseases is inadequate especially for specifically recommended vaccinesParental acceptance of an intranasal vaccine: Example of influenza vaccine
P50
Q34576023-6219565D-E10B-49BC-AB07-ECD374220EEFQ34576309-2FEEC748-5200-4421-9850-0260E3FA4BEAQ37452663-F5AD15B3-2141-4052-9ADF-05F0234A7AB7Q37962236-1045093B-6FF6-4164-9359-A51B2BC6B3E0Q38009393-B580CAA5-FFEF-4518-B5C4-5D48EB96F2D3Q40349813-2EDC4A57-7B8E-43CB-945C-C8418A0284FDQ40384746-4310FF8D-F2E7-44D2-920D-5E15E3510A1AQ43161163-D35ACA12-686A-42F9-AA2C-F5D4E4EF5C00Q45120251-7C0B792E-AD47-457B-B069-57D52C41C3F2Q57469824-5D01CA90-BE4B-414E-A24D-A9A68F0614B4Q57792608-74263D9B-D476-47C0-A76E-7C3D4AD2999FQ57792705-5C3F7DCB-67EA-4813-8378-86B12023985FQ57792768-1A55D172-BDEB-4D8A-B652-1D9F5FEBDF16Q57792790-3AC54997-6FD9-45B8-BDD1-EDFD7B6DB108Q59412758-0E2B1691-41BB-4278-B6F8-623ABAC83C57Q80420776-0A6E2F65-2271-4B2B-B83B-0F10900C6913Q80552162-E4180CC4-6CAF-4B10-B900-75FB8EA441CAQ80716497-4F5DD180-017B-48D1-8E27-2B247F6F6DBDQ81918104-DDC1FB8F-204C-4917-92F5-0CEB640DAEE6Q87066105-AB249CBB-D895-460E-84D4-2DC08B5B3F27Q90840349-CFCB956C-403F-4644-BC88-5CA3828ADD27Q91115977-4CD7235D-83DC-4996-84D8-30CAC2D91A7E
P50
description
researcher ORCID ID = 0000-0003-2151-1638
@en
wetenschapper
@nl
name
Francois Dubos
@ast
Francois Dubos
@en
Francois Dubos
@es
Francois Dubos
@nl
type
label
Francois Dubos
@ast
Francois Dubos
@en
Francois Dubos
@es
Francois Dubos
@nl
prefLabel
Francois Dubos
@ast
Francois Dubos
@en
Francois Dubos
@es
Francois Dubos
@nl
P106
P31
P496
0000-0003-2151-1638